Dr. Vince Clinical Research
Steven Hull, MD, is a seasoned Sleep Medicine Specialist, Internist, and Pulmonologist with over 30 years of experience. Currently serving as Medical Director and Principal Investigator at Dr. Vince Clinical Research since May 2022, Steven previously held the position of President at Midwest Sleep Specialists, LLC from October 2000 to August 2018. Steven's career includes a role as Associate Medical Director at Kaiser Permanente from January 1997 to 2000, and leadership experience as a former CEO of a publicly traded company in Australia. Additionally, Steven has contributed to the academic community as an Associate Editor for "Sleep" and "The Journal of Clinical Sleep Medicine." Educational credentials include a Doctor of Medicine from Southern Illinois University School of Medicine, followed by an Internal Medicine residency at the University of Illinois College of Medicine at Peoria, and a Pulmonary and Critical Care fellowship at the University of Kansas Medical Center.
Dr. Vince Clinical Research
Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and multiple therapeutic areas such as neuroscience, psychiatry, substance abuse, pain, cardiometabolic disorders, infectious diseases and others. CRO services include project management, data management, biostatistics, monitoring, PK/PD analysis, medical writing as well as site feasibility and management for multi-center trials. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients.